Role of PI3 kinase gamma in excitation-contraction coupling and heart disease

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 7, Issue 4, 2007, Pages 295-304

  Oudit, Gavin Y ^a   Kassiri, Zamaneh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE BETA; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHODIESTERASE; PHOSPHOLAMBAN; PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; BIOMECHANICS; CARDIOVASCULAR DISEASE; CATALYSIS; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL SIZE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME STRUCTURE; EXCITATION CONTRACTION COUPLING; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; INFLAMMATORY DISEASE; MECHANOTRANSDUCTION; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM; CYCLIC AMP; DRUG DELIVERY SYSTEMS; HEART DISEASES; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 37349012900     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152907782793545     Document Type: Review

References (127)

1. Oudit, G.Y.; Sun H.; Kerfant, B.G, Crackower, M.A.; Penninger, J.M.; Backx, P.H.; The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell Cardiol., 2004, 37, 449-71.
2. Stephens, L.R.; Jackson, T.R.; Hawkins, P.T.; Agonist-stimulated synthesis of phosphatidylinositol(3, 4, 5)-trisphosphate: a new intracellular signalling system? Biochim. Biophys. Acta, 1993, 1179, 27-75.
3. Vanhaesebroeck, B.; Leevers, SJ.; Ahmadi, K.; Timms, J.; Katso, R.; Driscoll, P.C.; Woscholski, R, Parker, PJ, Waterfield, MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem., 2001, 70, 535-602.
4. Foster, F.M.; Traer, C.J.; Abraham, S.M.; Fry, M.J.; The phosphoinositide (PI) 3-kinase family. J. Cell Sci., 2003, 116, 3037-40.
5. Wymann, M.P.; Zvelebil, M.; Laffargue, M.; Phosphoinositide 3-kinase signalling - which way to target? Trends. Pharmacol. Sci., 2003, 24, 366-76.
6. Kessler, A.; Uphues, I, Ouwens, D.M.; Till, M.; Eckel, J. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase. Am. J. Physiol. Endocrinol. Metab., 2001, 280, E65-74.
7. Chen, D.; Mauvais-Jarvis, F.; Bluher, M.; Fisher, SJ.; Jozsi, A.; Goodyear, LJ.; Ueki, K.; Kahn, CR. p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol. Cell Biol., 2004, 24, 320-9.
8. Antonetti, D.A.; Algenstaedt, P.; Kahn, C.R., Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell Biol., 1996, 16, 2195-203.
9. Crackower, M.A.; Oudit, G.Y.; Kozieradzki, I.; Sarao, R.; Sun, H.; Sasaki, T.; Hirsch, E.; Suzuki, A.; Shioi, T.; Irie-Sasaki, J.; Sah, R.; Cheng, H.Y.; Rybin, V.O.; Lembo, G.; Fratta, L.; Oliveira-dos-Santos, A.J.; Benovic, J.L.; Kahn, C.R.; Izumo, S.; Steinberg, S.F.; Wymann, M.P.; Backx, P.H.; Penninger, J.M. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell, 2002, 110, 737-49.
10. Stephens, L.R.; Eguinoa, A.; Erdjument-Bromage, H.; Lui, M.; Cooke, F.; Coadwell, J.; Smrcka, A.S.; Thelen, M.; Cadwallader, K.; Tempst, P.; Hawkins, P.T. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell, 1997, 89, 105-14.
11. Walker E.H.; Perisic O.; Ried C.; Stephens L.; Williams R.L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature, 1999, 402, 313-20.
12. Northcott C.A.; Poy M.N.; Najar S.M.; Watts S.W. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ. Res., 2002, 91, 360-9.
13. Oudit, G.Y.; Crackower, M.A, Eriksson, U.; Sarao, R.; Kozieradzki, I.; Sasaki, T.; Irie-Sasaki, J.; Gidrewicz, D.; Rybin V.O.; Wada, T.; Steinberg, S.F.; Backx, P.H.; Penninger, J.M. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation, 2003, 108, 2147-52.
14. Bacqueville, D.; Deleris, P.; Mendre, C.; Pieraggi, M.T.; Chap, H.; Guillon, G.; Perret, B.; Breton-Douillon, M. Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei. J. Biol. Chem., 2001, 276, 22170-6.
15. Quignard, J.F.; Mironneau, J.; Carricaburu, V.; Fournier, B.; Babich, A.; Nurnberg, B.; Mironneau, C.; Macrez, N. Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. J. Biol. Chem., 2001, 276, 32545-51.
16. Cieslik, K.; Abrams, C. S.; Wu, K.K. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma/Janus kinase 2/MEK-1-dependent pathway. J. Biol. Chem., 2001, 276, 1211-9.
17. Yu, J.; Zhang, Y.; McIlroy, J.; Rordorf-Nikolic, T.; Orr, G.A.; Backer, J.M. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol. Cell Biol., 1998, 18, 1379-87.
18. Mauvais-Jarvis, F.; Ueki, K.; Fruman, D.A.; Hirshman, M.F.; Sakamoto, K.; Goodyear, L.J.; Iannacone, M.; Accili, D.; Cantley, L.C.; Kahn, C.R. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest., 2002, 109, 141-9.
19. Pawson, T. Specificity in Signal Transduction. From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems. Cell, 2004, 116, 191-203.
20. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell, 2000, 103, 211-25.
21. Cantley, L.C. The phosphoinositide 3-kinase pathway. Science, 2002, 296, 1655-7.
22. Stoyanov, B.; Volinia, S.; Hanck, T.; Rubio, I.; Loubtchenkov, M.; Malek, D.; Stoyanova, S.; Vanhaesebroeck, B.; Dhand, R.; Nurnberg, B.; et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science, 1995, 269, 690-3.
23. Brock, C.; Schaefer, M.; Reusch, H.P.; Czupalla, C.; Michalke, M.; Spicher, K.; Schultz, G.; Nurnberg, B. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J. Cell Biol., 2003, 160, 89-99.
24. Pacold, M.E.; Suire, S.; Perisic, O.; Lara-Gonzalez, S.; Davis, C.T.; Walker, E.H.; Hawkins, P.T.; Stephens, L.; Eccleston, J.F.; Williams, R.L. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell, 2000, 103, 931-43.
25. Sugden PH. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ. Res., 2003, 93, 1179-92.
26. Bers, D.M. Cardiac excitation-contraction coupling. Nature, 2002, 415, 198-205.
27. Bers, D.M.; Eisner, D.A.; Valdivia, H.H. Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ. Res., 2003, 93, 487-90.
28. Keely, S.L. Prostaglandin, E.I. activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force. Mol. Pharmacol., 1979, 15, 235-45.
29. Jurevicius J, Fischmeister R. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc. Natl. Acad. Sci. USA, 1996, 93, 295-9.
30. Vila Petroff, M.G.; Egan, J.M.; Wang, X.; Sollott, S.J. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ. Res., 2001, 89, 445-52.
31. Fischmeister, R.; Castro, L.R.; Abi-Gerges, A.; Rochais, F.; Jurevicius, J.; Leroy, J.; Vandecasteele, G. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ. Res., 2006, 99, 816-28.
32. Steinberg, S.F.; Brunton, L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 751-73.
33. Bers, D.M.; Ziolo, M.T. When is cAMP not cAMP? Effects of compartmentalization. Circ. Res., 2001, 89, 373-5.
34. Baillie, G.S.; Scott, J.D.; Houslay, M.D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett., 2005, 579, 3264-70.
35. Georget, M.; Mateo, P.; Vandecasteele, G.; Lipskaia, L.; Defer, N.; Hanoune, J.; Hoerter, J.; Lugnier, C.; Fischmeister, R. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). FASEB J., 2003, 17, 1380-91.
36. Lehnart, S.E.; Wehrens, X.H.; Reiken, S.; Warrier, S.; Belevych, A.E.; Harvey, R.D.; Richter, W.; Jin, S.L.; Conti, M.; Marks, A.R. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell, 2005, 123, 25-35.
37. Bauman, A.L.; Scott, J.D. Kinase- and phosphatase-anchoring proteins: hamessing the dynamic duo. Nat. Cell Biol., 2002, 4, E203-6.
38. Wong, W.; Scott, J.D. AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol., 2004, 5, 959-70.
39. Hirsch, E.; Katanaev, V.L.; Garlanda, C.; Azzolino, O.; Pirola, L.; Silengo, L.; Sozzani, S.; Mantovani, A.; Altruda, F.; Wymann, M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science, 2000, 287, 1049-53.
40. Sasaki, T.; Irie-Sasaki, J.; Jones, R.G.; Oliveira-dos-Santos, AJ, Stanford, WL, Bolon, B, Wakeham, A.; Itie, A.; Bouchard, D.; Kozieradzki, I.; Joza, N.; Mak, T.W.; Ohashi, P.S.; Suzuki, A.; Penninger, J.M. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science, 2000, 287, 1040-6.
41. Li, Z.; Jiang, H.; Xie, W.; Zhang, Z.; Smrcka, A. V.; Wu, D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science, 2000, 287, 1046-9.
42. Nienaber, J.J.; Tachibana, H.; Naga, Prasad, S. V.; Esposito, G.; Wu, D.; Mao, L.; Rockman, H.A. hibibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J. Clin. Invest., 2003, 112, 1067-79.
43. Patrucco, E.; Notte, A.; Barberis, L.; Selvetella, G.; Maffei, A.; Brancaccio, M.; Marengo, S.; Russo, G.; Azzolino, O.; Rybalkin, S.D.; Silengo, L.; Altruda F.; Wetzker, R.; Wymann, M.P.; Lembo, G..; Hirsch, E. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and - independent effects. Cell, 2004, 118, 375-87.
44. Alloatti, G.; Marcantoni, A.; Levi, R.; Gallo, M.P.; Del Sorbo, L.; Patrucco, E.; Barberis, L.; Malan, D.; Azzolino O.; Wymann, M.; Hirsch, E.; Montrucchio, G. Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level. FEBS Lett., 2005, 579, 133-40.
45. Kerfant, B.G.; Gidrewicz, D.; Sun, H.; Oudit, G.Y.; Penninger, J.M.; Backx, P.H. Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kgamma-deficient mice. Circ. Res., 2005, 96, 1079-86.
46. MacLennan, D.H.; Kranias, E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol., 2003, 4, 566-77.
47. Sun, H.; Kerfant, B.G.; Zhao, D.; Trivieri, M.G.; Oudit, G.Y.; Penninger, J.M.; Backx P.H. Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha/ PKB signaling. Circ. Res., 2006, 98, 1390-7.
48. Leblais, V.; Jo, S.H.; Chakir, K.; Maltsev, V.; Zheng, M.; Crow, M.T.; Wang, W.; Lakatta, E.G.; Xiao, R.P. Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. Circ. Res., 2004, 95, 1183-90.
49. Chesley, A.; Lundberg, M.S.; Asai, T.; Xiao, R.P.; Ohtani, S.; Lakatta, E.G.; Crow, M.T. Th beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ. Res., 2000, 8, 1172-9.
50. Zhu, W.Z.; Zheng, M.; Koch, W.J.; Lefkowitz, R.J.; Kobilka, B.K.; Xiao, R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci USA, 2001, 98, 1607-12.
51. Jo, S.H.; Leblais, V.; Wang, P.H.; Crow, M.T.; Xiao, R.P. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ. Res., 2002, 91, 46-53.
52. Verde, I.; Vandecasteele, G.; Lezoualc'h, F, Fischmeister, R. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Br. J. Pharmacol., 1999, 127, 65-74.
53. Mongillo, M.; McSorley, T.; Evellin, S.; Sood, A.; Lissandron, V.; Terrin, A.; Huston, E.; Hannawacker, A.; Lohse, M.J.; Pozzan, T.; Houslay, M.D.; Zaccolo, M. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in five neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ. Res., 2004, 95, 67-75.
54. Sahu, A.; Metlakunta, A.S. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signaling is impaired following chronic central leptin infusion. J. Neuroendocrinol., 2005, 17, 720-6.
55. Beavo, J.A. Cyclic nucleutide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 1995, 75, 725-48.
56. Movsesian, M.A. PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes. Basic. Res. Cardiol., 2002, 97(Suppl. 1), 183-90.
57. Maurice, D.H.; Palmer, D.; Tilley, D.G.; Dunkerley, H.A.; Netherton. S.J.; Raymond, D.R.; Elbatarny, H.S.; Jimmo, S.L. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol. Pharmacol., 2003, 64, 533-46.
58. Voigt, P.; Dorner, M.B.; Schaefer, M. Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B. J. Biol. Chem., 2006, 281, 9977-86.
59. Houslay, M.D.; Baillie, G.S.; Maurice, D.H. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ. Res., 2007, 100, 950-66.
60. Perry, S.J.; Baillie, G.S.; Kohout, T.A.; McPhee, I.; Magiera, M.M.; Ang, K.L.; Miller, W.E.; McLean A.J.; Conti M.; Houslay M.D.; Lefkowitz R.J. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science, 2002, 298, 834-6.
61. Camps, M.; Ruckle, T.; Ji, H.; Ardissone, V.; Rintelen, F.; Shaw, J.; Ferrandi, C.; Chabert, C.; Gillieron, C.; Francon, B.; Martin, T.; Gretener, D.; Perrin, D.; Leroy, D.; Vitte, P.A.; Hirsch, E.; Wymann, M.P.; Cirillo, R.; Schwarz, M.K.; Rommel, C. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med., 2005, 11, 936-43.
62. Nikolaev, V.O.; Bunemann, M.; Schmitteckert, E.; Lohse, M.J.; Engelhardt, S. Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching (beta) 1-Adrenergic but Locally Confined {beta}2-Adrenergic Receptor-Mediated Signaling. Circ. Res., 2006, 99, 1084-91.
63. Baillie, G.S.; Sood, A.; McPhee, I.; Gall, I.; Perry, S.J.; Lefkowitz, R.J.; Houslay, M.D. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc. Natl. Acad. Sci. USA, 2003, 100, 940-5.
64. Naga Prasad, S.V.; Barak, L.S.;. Rapacciuolo, A.; Caron, M.G.; Rockman, H.A. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J. Biol. Chem., 2001, 276, 18953-9.
65. Naga Prasad, S,V; Jayatillcke, A.; Madamanchi, A.; Rockman, H.A. Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat. Cell Biol., 2005, 7, 785-96.
66. Pavoine, C.; Defer, N. The cardiac beta2-adrenergic signalling a new role for the cPLA2. Cell Signal., 2005, 17, 141-52.
67. Zhou, Y.Y.; Song, L.S.; Lakatta, E.G.; Xiao, R.P.; Cheng, H. Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart. J. Physiol., 1999, 521 (Pt 2), 351-61.
68. Kuschel, M.; Zhou, Y.Y.; Cheng, H.; Zhang, S.J.; Chen, Y.; Lakatta, E.G.; Xiao, R.P. G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J. Biol. Chem., 1999, 274, 22048-52.
69. Chen-Izu, Y.; Xiao, R.P.; Izu, L.T.; Cheng, H.; Kuschel, M.; Spurgeon, H.; Lakatta, E.G. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels. Biophys. J., 2000, 79, 2547-56.
70. Wang, Y.G.; Dedkova, E.N.; Steinberg, S.F.; Blatter, L.A.; Lipsius, S.L. Beta 2-adrenergic receptor signaling acts via NO release to mediate ACh-induced activation of ATP-sensitive K+ current in cat atrial myocytes. J. Gen. Physiol., 2002, 119, 69-82.
71. Dedkova, E.N.; Wang, Y.G.; Blatter, L.A.; Lipsius, S.L. Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes. J. Physiol., 2002, 542, 711-23.
72. Li, B.; Setoguchi, M.; Wang, X.; Andreoli, A.M.; Leri, A.; Malhotra, A.; Kajstura, J.; Anversa, P. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ. Res., 1999, 84, 1007-19.
73. Matsui, T.; Tao, J.; del Monte, F.; Lee, K.H.; Li, L.; Picard, M.; Force, T.L.; Franke, T.F.; Hajjar, R.J.; Rosenzweig, A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation, 2001, 104, 330-5.
74. Yamashita, K.; Kajstura, J.; Discher, DJ.; Wassertauf, B.J.; Bishopric, N.H.; Anversa, P.; Webster, K.A. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ. Res., 2001, 88, 609-14.
75. Zou, Y.; Zhu, W.; Sakamoto, M.; Qin, Y.; Akazawa, H.; Toko, H.; Mizukami, M.; Takeda, N.; Minamino, T.; Takano, H.; Nagai, T.; Nakai, A.; Komuro, I. Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury. Circulation, 2003, 108, 3024-30.
76. Duan, J.; Zhang, H.Y.; Adkins, S.D.; Ren, B.H.; Norby, F.L.; Zhang, X.; Benoit, J.N.; Epstein, P.N.; Ren, J. Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. Am. J. Physiol. Endocrinol. Metab., 2003, 284, E366-76.
77. Belke, D.D.; Betuing, S.; Tuttle, M.J.; Graveleau, C.; Young, M.; Pham, M.; Zhang, D.; Cooksey, R.C.; McClain, D.A.; Litwin, S.E.; Taeguneyer, H.; Severson, D.; Kahn, C.R.; Abel, E.D. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest., 2002, 109, 629-39.
78. Negoro, S.; Oh, H.; Tone, E.; Kunisada, K.; Fujio, Y.; Walsh, K.; Kishimoto, T.; Yamauchi-Takihara, K. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorytation and Bcl-xL/caspase-3 interaction. Circulation, 2001, 103, 555-61.
79. Taniyama, Y.; Walsh, K. Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J. Mol. Cell Cardiol, 2002, 34, 1241-7.
80. Naga Prasad, S.V.; Esposito, G.; Mao, L.; Koch, W.J.; Rockman, H.A. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pessure overload hypertrophy. J. Biol. Chem., 2000, 275, 4693-8.
81. Esposito, G.; Rapacciuolo, A.; Naga Prasad, S.V.; Takaoka, H.; Thomas, S.A.; Koch, W.J.; Rockman, H.A. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation, 2002, 105, 85-92.
82. Haq, S.; Kilter, H.; Michael, A.; Tao, J.; O'Leary, E.; Sun, X.M.; Walters, B.; Bhattacharya, K, Chen, X, Cui, L, Andreucci, M, Rosenzweig, A, Guerrero, J.V.; Patten, R, Liao, R, Molkentin, J.; Picard, M.; Bonventre, J.V.; Force, T. Deletion of cytosolic phospholipase A(2) promotes striated muscle growth. Nat. Med., 2003, 9, 944-51.
83. Haq, S.; Choukroun, G.; Lim, H.; Tymitz, K.M.; del Monte, F.; Gwathmey, J.; Grazette, L.; Michael, A.; Hajjar, R.; Force, T.; Molkentin, J.D. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation, 2001, 103, 670-7.
84. Baba, H.A, Stypmann, J.; Grabellus, F.; Kirchhof, P.; Sokoll, A.; Schafers, M.; Takeda, A.; Wilhelm, M.J.; Scheld, H.H.; Takeda, N.; Breithardt, G.; Levkau, B. Dynamic regulation of MEK/Erks and Akt/ GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc. Res. 2003, 59, 390-9.
85. Esposito, G.; Prasad, S.V.; Rapacciuolo, A.; Mao, L.; Koch, W.J.; Rockman, H.A. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation, 2001, 103, 1453-8.
86. Hein, L.; Altman, J.D.; Kobilka, B.K. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature, 1999, 402, 181-4.
87. Scheuer, J. Catecholamines in cardiac hypertrophy. Am. J. Cardiol., 1999, 83, 70H-74H.
88. Brede, M.; Wiesmann, F.; Jahns, R.; Hadamek, K.; Arnolt, C.; Neubauer, S.; Lobse, M.J.; Hein, L. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation, 2002, 106, 2491-6.
89. Port J.D.; Bristow, M.R. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell Cardiol., 2001, 33, 887-905.
90. Dash, R.; Kadambi, V.; Schmidt, A.G.; Tepe, N.M.; Biniakiewicz, D.; Gerst, M.J.; Canning, A.M.; Abraham, W.T.; Hoit, B.D.; Liggett, S.B.; Lorenz, J.N.; Dorn, G.W., 2nd, Kranias, EG. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation, 2001, 103, 889-96.
91. Rapacciuolo, A.; Esposito, G.; Caron, K.; Mao, L.; Thomas, S.A.; Rockman, H.A. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol., 2001, 38, 876-82.
92. Rockmart, H.A.; Koch, W.J.; Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature, 2002, 415, 206-12.
93. Lefkowitz, R.J.; Rockman, H.A.; Koch, W.J. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation, 2000, 101, 1634-7.
94. Perez, J.M.; Rathz, D.A.; Petrashevskaya, N.N.; Hahn, H.S.; Wagoner, L.E.; Schwartz, A.; Dorn, G.W, Liggett, S.B. beta(1)-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat. Med., 2003, 9, 1300-5.
95. Hajjar, R.J.; MacRae, CA. Adrenergic-receptor polymorphisms and heart failure. N. Engl. J. Med., 2002, 347, 1196-9.
96. Small, K.M.; Wagoner, L.E.; Levin, A.M.; Kardia, S.L.; Liggett, S.B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med., 2002, 347, 1135-42.
97. Kass, D.A. beta-receptor polymorphisms: heart failure's crystal ball. Nat. Med., 2003, 9, 1260-2.
98. Zou, Y.; Yao, A.; Zhu, W.; Kudoh, S.; Hiroi, Y.; Shimoyama, M.; Uozumi, H.; Kohmoto, O.; Takahashi, T.; Shibasaki, F.; Nagai, R.; Yazaki, Y.; Komuro, I. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation, 2001, 104, 102-8.
99. Zou, Y.; Komuro, I.; Yamazaki, T.; Kudoh, S.; Uozumi, H.; Kadowaki, T.; Yazaki, Y. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J. Biol. Chem., 1999, 274, 9760-70.
100. Communal, C.; Colucci, W.S.; Singh, K. p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J. Biol. Chem., 2000, 275, 19395-400.
101. Simm, A.; Schluter, K.; Diez, C.; Piper, H.M.; Hoppe, J. Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J. Mol. Cell. Cardiol., 1998, 30, 2059-67.
102. Schwartzbauer, G.; Robbins, J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem., 2001, 276, 35786-93.
103. Tian, B.; Liu, J.; Bitterman, P.; Bache, R.J. Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/ PKB. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H1105-12.
104. Tsuruda, T.; Costello-Boerrigter, L.C.; Burnett, J.C. Jr. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail. Rev., 2004, 9, 53-61.
105. Zhang, D.; Gaussin, V.; Taffet, G.E.; Belaguli, N.S.; Yamada, M.; Schwartz, R.J.; Michael, L.H., Overbeek, P.A.; Schneider, M.D. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med., 2000, 6, 556-63.
106. Zhang, S.; Weinheimer, C.; Courtois, M.; Kovacs, A.; Zhang, C.E.; Cheng, A.M.; Wang, Y.; Muslin, A.J. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest., 2003, 111, 833-41.
107. Kilts, J.D.; Akazawa, T.; Richardson, M.D.; Kwatra, M.M. Age increases cardiac Galpha(i2) expression, resulting in enhanced coupling to G protein-coupled receptors. J. Biol. Chem., 2002, 277, 31257-62.
108. El-Armouche, A.; Zolk, O.; Rau, T.; Eschenhagen, T.. Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc. Res., 2003, 60, 478-87.
109. Alloatti, G.; Levi, R.; Malan, D.; Del Sorbo, L.; Bosco, O.; Barberis, L.; Marcantoni, A.; Bedendi, I.; Penna, C.; Azzotino, O.; Altruda, F.; Wymann, M.; Hirsch, E.; Montrucchio, G. Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Cardiovasc. Res., 2003, 60, 242-9.
110. Schmitt, J.P.; Kamisago, M.; Asahi, M.; Li, G.H.; Ahmad, F.; Mende, U.; Kranias, E.G.; MacLennan, D.H.; Seidman, J.G.; Seidman, C.E. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science, 2003, 299, 1410-3.
111. Chien, KR, Ross, J, Jr.; Hoshijima, M. Calcium and heart failure: the cycle game. Nat. Med., 2003, 9, 508-9.
112. Movsesian, M.A. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate. J. Am. Coll. Cardiol., 1999, 34, 318-24.
113. Haq, S.; Choukroun, G.; Kang, Z.B.; Ranu, H.; Matsui, T.; Rosenzweig, A.; Molkentin, J.D.; Alessandrini, A.; Woodgett, J.; Hajar, R.; Michael, A.; Force T. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J. Cell. Biol., 2000, 151, 117-30.
114. Antos, C.L.; McKinsey, T.A.; Frey, N.; Kutschke, W.; McAnally, J.; Shelton, J.M.; Richardson, J.A.; Hill, J.A.; Olson, E.N. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad Sci. USA, 2002, 99, 907-12.
115. Shioi, T.; McMullen, J.R.; Tarnavski, O.; Converso, K.; Sherwood, M.C.; Manning, W.J.; Izumo, S. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation, 2003, 107, 1664-70.
116. Ma, A.D.; Metjian, A.; Bagrodia, S.; Taylor, S.; Abrams, C.S. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac. Mol. Cell. Biol., 1998, 18, 4744-51.
117. Larsen, M.; Tremblay, M.L.; Yamada, K.M. Phosphatases in cell-matrix adhesion and migration. Nat. Rev. Mol. Cell. Biol., 2003, 4, 700-11.
118. Czech, M.P. PIP2 and PIP3: complex roles at the cell surface. Cell, 2000, 100, 603-6.
119. Okkenhaug, K.; Vanhaesebroeck, B. New responsibilities for the P13K regulatory subunit p85 alpha. Sci.STKE, 2001, PE1.
120. Dyson, J.M.; O'Malley, C.J.; Becanovic, J.; Munday, A.D.; Berndt, M.C.; Coghill, I.D.; Nandurkar, H.H.; Ooms, L.M.; Mitchell, C.A. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell. Biol., 2001, 155, 1065-79.
121. Oudit, G.Y.; Kassiri, Z.; Crackower, M.A.; Penninger, J.M.; Backx, P.H. Loss of P13 kinase gamma leads to an accelerated progression to dilated cardiomyopathy in response to pressure overload. Circulation, 2004, 108, IV-238.
122. Gwathmey, J.K.; Copelas, L.; MacKinnon, R.; Schoen, F.J.; Feldman, M.D.; Grossman, W.; Morgan, J.P. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ. Res., 1987, 61, 70-6.
123. Gomez, A.M.; Valdivia, H.H.; Cheng, H.; Lederer, M.R.; Santana, L.F.; Cannell, M.B.; McCune, S.A.; Altschuld, R.A.; Lederer, W.J. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure [see comments]. Science, 1997, 276, 800-6.
124. Piacentino, V., 3rd, Weber, C.R.; Chen, X.; Weisser-nomas, J.; Margulies, K.B.; Bers, D.M.; Houser, S.R. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res., 2003, 92, 651-8.
125. Naga Prasad, S. V.; Perrino, C.; Rockman, H.A. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Trends. Cardiovasc. Med., 2003, 13, 206-12.
126. Takahashi, K.; Osanai, T.; Nakano, T.; Wakui, M.; Okumura, K. Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure. Heart Vessels., 2002, 16, 249-56.
127. Bohm, M.; Flesch, M.; Schnabel, P. Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J. Mol. Med., 1997, 75, 842-8.